First Time Loading...

Henan Lingrui Pharmaceutical Co Ltd
SSE:600285

Watchlist Manager
Henan Lingrui Pharmaceutical Co Ltd Logo
Henan Lingrui Pharmaceutical Co Ltd
SSE:600285
Watchlist
Price: 24.85 CNY -0.84% Market Closed
Updated: May 18, 2024
Henan Lingrui Pharmaceutical Co Ltd
/
Income Statement
/
Interest Income Expense

Henan Lingrui Pharmaceutical Co Ltd
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Henan Lingrui Pharmaceutical Co Ltd
Interest Income Expense Peer Comparison

Comparables:
H
3692
600436
600276
000538
S
688506

Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
Henan Lingrui Pharmaceutical Co Ltd
SSE:600285
Interest Income Expense
¥47.4m
CAGR 3-Years
41%
CAGR 5-Years
N/A
CAGR 10-Years
-3%
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Interest Income Expense
¥1.1B
CAGR 3-Years
52%
CAGR 5-Years
82%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Interest Income Expense
¥134.5m
CAGR 3-Years
7%
CAGR 5-Years
4%
CAGR 10-Years
23%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Interest Income Expense
¥429.9m
CAGR 3-Years
-8%
CAGR 5-Years
4%
CAGR 10-Years
30%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Interest Income Expense
¥1.1B
CAGR 3-Years
-16%
CAGR 5-Years
-11%
CAGR 10-Years
37%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Interest Income Expense
-¥20.1m
CAGR 3-Years
-107%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Henan Lingrui Pharmaceutical Co Ltd's Interest Income Expense?
Interest Income Expense
47.4m CNY

Based on the financial report for Sep 30, 2023, Henan Lingrui Pharmaceutical Co Ltd's Interest Income Expense amounts to 47.4m CNY.

What is Henan Lingrui Pharmaceutical Co Ltd's Interest Income Expense growth rate?
Interest Income Expense CAGR 10Y
-3%

Over the last year, the Interest Income Expense growth was -46%. The average annual Interest Income Expense growth rates for Henan Lingrui Pharmaceutical Co Ltd have been 41% over the past three years , and -3% over the past ten years .

ALPHA SPREAD
Join more than 138,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.